Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.14B |
| 2 |
Microsoft
MSFT
|
+$2.98B |
| 3 |
UnitedHealth
UNH
|
+$2.85B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.59B |
| 5 |
CRH
CRH
|
+$2.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$2.01B |
| 2 |
Flutter Entertainment
FLUT
|
+$1.59B |
| 3 |
Welltower
WELL
|
+$841M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$798M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$752M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.01% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Coherus Oncology
CHRS
$217M
| $9M | ﹤0.01% |
11,151,905
-2,471
| -0% | -$2.84K |
|
2902
Bank7 Corp
BSVN
$479M
| $8.98M | ﹤0.01% |
231,898
-512
| -0.2% | -$21.4K |
|
2903
eHealth
EHTH
$42.2M
| $8.98M | ﹤0.01% |
1,343,632
+60,290
| +5% | +$548K |
|
2904
iShares Russell 2000 ETF
IWM
$79.8B
| $8.96M | ﹤0.01% |
44,926
-545
| -1% | -$118K |
|
2905
Pioneer Bancorp
PBFS
$432M
| $8.94M | ﹤0.01% |
763,055
-1,185
| -0.2% | -$13.8K |
|
2906
Greene County Bancorp
GCBC
$570M
| $8.93M | ﹤0.01% |
370,471
-5,281
| -1% | -$137K |
|
2907
4D Molecular Therapeutics
FDMT
$532M
| $8.91M | ﹤0.01% |
2,757,490
-103,018
| -4% | -$485K |
|
|
SRTA
2908
Strata Critical Medical Inc
SRTA
$434M
| $8.89M | ﹤0.01% |
3,254,875
+81,962
| +3% | +$294K |
|
2909
Gerdau
GGB
$9.74B
| $8.87M | ﹤0.01% |
3,122,472
-62,465
| -2% | -$182K |
|
2910
Biglari Holdings Class B
BH
$1.25B
| $8.86M | ﹤0.01% |
40,930
+3,469
| +9% | +$791K |
|
2911
Solid Power
SLDP
$463M
| $8.85M | ﹤0.01% |
8,432,869
+79,399
| +1% | +$109K |
|
2912
Smith Douglas Homes
SDHC
$124M
| $8.84M | ﹤0.01% |
452,897
| – | – |
|
2913
Vivid Seats
SEAT
$84.6M
| $8.82M | ﹤0.01% |
148,966
-95,915
| -39% | -$7.72M |
|
|
CTEV
2914
Claritev Corp
CTEV
$387M
| $8.79M | ﹤0.01% |
425,890
+27,830
| +7% | +$554K |
|
2915
AMES National
ATLO
$271M
| $8.75M | ﹤0.01% |
499,703
+2,049
| +0.4% | +$36.6K |
|
|
PLGO
2916
Pelagos Insurance Capital
PLGO
$2.16B
| $8.74M | ﹤0.01% |
539,748
+7,471
| +1% | +$119K |
|
2917
SoundThinking
SSTI
$100M
| $8.72M | ﹤0.01% |
514,175
-6,952
| -1% | -$103K |
|
|
FSP
2918
Franklin Street Properties
FSP
$47.2M
| $8.71M | ﹤0.01% |
4,894,257
+65,419
| +1% | +$121K |
|
|
LOGC
2919
DELISTED
ContextLogic
LOGC
| $8.68M | ﹤0.01% |
1,244,179
-21,836
| -2% | -$163K |
|
|
BBNX
2920
Beta Bionics
BBNX
$577M
| $8.68M | ﹤0.01% |
+709,255
| New | +$13.2M |
|
2921
Velocity Financial
VEL
$689M
| $8.68M | ﹤0.01% |
463,911
-693
| -0.1% | -$13K |
|
2922
Editas Medicine
EDIT
$396M
| $8.66M | ﹤0.01% |
7,466,254
+643,256
| +9% | +$946K |
|
|
PAL
2923
Proficient Auto Logistics
PAL
$190M
| $8.66M | ﹤0.01% |
1,034,474
+209,249
| +25% | +$2.07M |
|
2924
Electromed
ELMD
$337M
| $8.65M | ﹤0.01% |
362,388
| – | – |
|
|
YMAB
2925
DELISTED
Y-mAbs Therapeutics
YMAB
| $8.62M | ﹤0.01% |
1,946,509
-53,513
| -3% | -$311K |
|
Similar funds
Vanguard Group's Q1 2025 Portfolio in Review
As of Q1 2025, Vanguard Group held 4,371 positions worth $5.53T, down 3.7% from $5.74T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.9%. Vanguard Group opened 78 new positions and exited 91, leaving the 4,371-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- Vanguard Group's largest Q1 2025 buy was Sandisk: 13,684,572 shares worth $652M.
- Vanguard Group added most to Eli Lilly in Q1 2025, an estimated $4.14B increase.
- Vanguard Group's biggest Q1 2025 reduction was Palantir, cutting an estimated $2.01B.
- Vanguard Group fully exited Smartsheet Inc. in Q1 2025, selling an estimated $798M.
- Vanguard Group's ten largest holdings make up 26% of its $5.53T portfolio in Q1 2025.
- Vanguard Group opened 78 new positions and closed 91 in Q1 2025.
- Vanguard Group's portfolio value fell 3.7% quarter-over-quarter to $5.53T.
Based on Vanguard Group's 13F filing for Q1 2025, filed 9 May 2025.